In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Current standards in lowering lipid therapy in secondary prevention

Webinar from the ESC Working Group on Atherosclerosis and Vascular Biology

23/05/2018 18:00 23/05/2018 19:00 Europe/Paris Current standards in lowering lipid therapy in secondary prevention ESC Working Group on Atherosclerosis & Vascular Biology contact@escardio.org DD/MM/YYYY
Secondary Prevention
Vascular Biology and Physiology
Cardiovascular Pharmacotherapy
Lipids, Metabolism
Online
event

Focus on

Learning Objectives:

  • To review the benefits and limitations of the current lipid-lowering therapies.
  • To discuss the potential strategies to achieve adequate LDL goals in secondary prevention.
  • To discuss future approaches in the field of lipid-lowering therapy.


Watch the webinar recording

 

Faculty

Speakers

gitt-anselm.jpgDoctor Anselm Gitt, FESC
Herzzentrum Ludwigshafen
Dept. Of Cardiology
Ludwigshafen
Germany

 

Tunon-Jose-2018-(2).jpgAssociate Professor José Tunon, FESC
Fundación Jiménez Díaz
Servicio de Cardiología
Madrid

 Host

Bäck-Magnus-2018.jpgProfessor Magnus Back, FESC
Karolinska University Hospital
Department Of Cardiology
Stockholm, Sweden

 

 

Session Information

This webinar addresses General cardiologists but also:

  • Cardiologists specialising in atherothrombotic therapies where in-depth coverage of all relevant conditions
  • Cardiologists, General Internal doctors and specialists in angiology, pharmacotherapy, and interventional cardiologists
  • Clinical cardiologists, who would benefit from access to specific courses relating to Lipid-lowering therapies and CAD
  • Physicians involved in diagnosis and care of CAD and Lipid-lowering therapies

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).